Cargando…

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality

The impact of different types of physical activity (PA) on mortality in the context of nonalcoholic fatty liver disease (NAFLD) is not clearly defined and was investigated. This prospective study was performed using the 2007–2014 US National Health and Nutrition Examination Survey with mortality fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Donghee, Wijarnpreecha, Karn, Dennis, Brittany B., Cholankeril, George, Ahmed, Aijaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004264/ https://www.ncbi.nlm.nih.gov/pubmed/36902707 http://dx.doi.org/10.3390/jcm12051923

Ejemplares similares

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
por: Konyn, Peter, et al.
Publicado: (2023)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
por: Dibba, Pratima, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft
por: Liu, Andy, et al.
Publicado: (2018)

Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
por: Li, Andrew A., et al.
Publicado: (2020)

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2018)

Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age
por: Miller, Matthew J., et al.
Publicado: (2023)

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
por: Kim, Donghee, et al.
Publicado: (2021)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
por: Iqbal, Umair, et al.
Publicado: (2019)

Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2020)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation
por: Li, Andrew A., et al.
Publicado: (2018)

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019)

The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019
por: Danpanichkul, Pojsakorn, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2019)

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults
por: Sun, Xingxing, et al.
Publicado: (2021)

Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
por: Zheng, Jia-Rui, et al.
Publicado: (2023)

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States
por: Kim, Donghee, et al.
Publicado: (2017)

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States
por: Kang, Seung Joo, et al.
Publicado: (2018)

Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Insomnia and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
por: Wijarnpreecha, K, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
por: Cheung, Amanda, et al.
Publicado: (2021)

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease
por: Cholankeril, George, et al.
Publicado: (2017)

Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease
por: Chen, Yuxiong, et al.
Publicado: (2022)

Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease
por: Wong, Yu Jun, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies
por: Snyder, Heather S., et al.
Publicado: (2018)

Nonalcoholic fatty liver disease, circulating ketone bodies and all‐cause mortality in a general population‐based cohort
por: Post, Adrian, et al.
Publicado: (2021)

The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease
por: Zhao, Enfa, et al.
Publicado: (2023)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_50tpflhpcmmgr17dgf4nuj2q0r